In-depth story on Vasalgel

The Medical Daily published a comprehensive news article on the development of male contraceptives, highlighting Vasalgel’s journey to market. Journalist Stephanie Castillo interviewed Parsemus Foundation’s Director Elaine Lissner, who provided insight into why men are demanding new contraceptive options now more than ever. Lissner talked about Vasalgel’s timeline, cost and promise to revolutionize the way we think about birth control. Check out “Male Birth Control, Like Vasalgel, Is Closer To Becoming A Reality; Here’s Everything We Know So Far”.

Linda Brent, PhD

Executive Director, Parsemus Foundation

Tell us what you think

This field is for validation purposes and should be left unchanged.
We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today